ES2516866T3 - Medios y métodos para el diagnóstico de carcinomas de próstata - Google Patents

Medios y métodos para el diagnóstico de carcinomas de próstata Download PDF

Info

Publication number
ES2516866T3
ES2516866T3 ES10724454.3T ES10724454T ES2516866T3 ES 2516866 T3 ES2516866 T3 ES 2516866T3 ES 10724454 T ES10724454 T ES 10724454T ES 2516866 T3 ES2516866 T3 ES 2516866T3
Authority
ES
Spain
Prior art keywords
acid
metabolite
cis
mass spectrometry
detected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES10724454.3T
Other languages
English (en)
Spanish (es)
Inventor
Beate Kamlage
Bianca Bethan
Regina Reszka
Edgar Leibold
Klaus Jung
Michael Lein
Glen Kristiansen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Charite Universitaetsmedizin Berlin
Metanomics Health GmbH
Original Assignee
Charite Universitaetsmedizin Berlin
Metanomics Health GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Charite Universitaetsmedizin Berlin, Metanomics Health GmbH filed Critical Charite Universitaetsmedizin Berlin
Application granted granted Critical
Publication of ES2516866T3 publication Critical patent/ES2516866T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57555—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
ES10724454.3T 2009-06-04 2010-06-02 Medios y métodos para el diagnóstico de carcinomas de próstata Active ES2516866T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09161956 2009-06-04
EP09161956 2009-06-04
PCT/EP2010/057680 WO2010139711A1 (en) 2009-06-04 2010-06-02 Means and methods for diagnosing prostate carcinomas

Publications (1)

Publication Number Publication Date
ES2516866T3 true ES2516866T3 (es) 2014-10-31

Family

ID=42320338

Family Applications (1)

Application Number Title Priority Date Filing Date
ES10724454.3T Active ES2516866T3 (es) 2009-06-04 2010-06-02 Medios y métodos para el diagnóstico de carcinomas de próstata

Country Status (9)

Country Link
US (1) US20120122243A1 (https=)
EP (3) EP2804001B1 (https=)
JP (2) JP5933432B2 (https=)
CN (1) CN102483416A (https=)
CA (1) CA2764049A1 (https=)
DE (1) DE112010002253T5 (https=)
ES (1) ES2516866T3 (https=)
PL (1) PL2438445T3 (https=)
WO (1) WO2010139711A1 (https=)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101821551B1 (ko) 2008-06-20 2018-01-25 아지노모토 가부시키가이샤 전립선 질환의 평가 방법
US9285378B2 (en) 2010-01-29 2016-03-15 Metanomics Gmbh Means and methods for diagnosing heart failure in a subject
TWI596494B (zh) 2012-03-05 2017-08-21 Ｏｐｋｏ診斷法有限責任公司 預測前列腺癌風險及前列腺腺體體積之方法及裝置
ES2688121T3 (es) 2012-10-02 2018-10-31 Metanomics Health Gmbh Medios y procedimientos de diagnóstico de la reaparición de cáncer de próstata después de prostatectomía
JP2014169955A (ja) * 2013-03-05 2014-09-18 Seiko Epson Corp 分析装置、分析方法、これらに用いる光学素子および電子機器、並びに光学素子の設計方法
JP6201369B2 (ja) * 2013-03-28 2017-09-27 セイコーエプソン株式会社 検出装置及び電子機器
ES2534732B1 (es) * 2013-08-05 2016-04-21 Servicio Andaluz De Salud Método de clasificación, diagnóstico y seguimiento de individuos con riesgo de padecer cáncer de pulmón mediante el análisis de sudor
JP6222629B2 (ja) * 2013-08-29 2017-11-01 花王株式会社 排尿障害のバイオマーカー
JP2015055482A (ja) * 2013-09-10 2015-03-23 セイコーエプソン株式会社 分析装置、分析方法、これらに用いる光学素子及び電子機器
KR101838133B1 (ko) 2013-10-04 2018-03-14 주식회사 씨스퀘어 사르코신 대사산물 중 포름알데히드를 이용한 전립선암 진단 시험지, 그 제조 방법 및 이를 이용한 전립선암 진단에 필요한 정보를 제공하는 방법
GB201322034D0 (en) 2013-12-12 2014-01-29 Almac Diagnostics Ltd Prostate cancer classification
US10274496B2 (en) 2014-01-17 2019-04-30 University Of Washington Biomarkers for detecting and monitoring colon cancer
US20180217125A1 (en) * 2014-03-26 2018-08-02 Metanomics Health Means and methods for the determination of the quality of blood samples based on a metabolite panel
US12326453B2 (en) 2014-03-28 2025-06-10 Opko Diagnostics, Llc Compositions and methods for active surveillance of prostate cancer
KR102505543B1 (ko) * 2014-03-28 2023-03-02 옵코 다이어그노스틱스, 엘엘씨 전립선암 진단에 관한 조성물 및 방법
JP5796863B1 (ja) * 2014-10-31 2015-10-21 節郎 山田 腫瘍検査用組成物及び腫瘍検査用試験紙
CN104614462B (zh) * 2015-02-11 2016-09-14 中国人民解放军第四军医大学 一种高原肺水肿诊断标志物及其应用和诊断试剂盒
PT3253800T (pt) 2015-03-27 2021-04-28 Opko Diagnostics Llc Padrões de antigénio da próstata e suas utilizações
EP3229026A1 (en) * 2016-04-06 2017-10-11 Universite De Bordeaux Biomarkers for the diagnosis of inflammation-related diseases
EP3465202B1 (en) * 2016-06-02 2023-07-05 Metabolon, Inc. Mass spectrometry method for detection and quantitation of metabolites
CN116148481A (zh) * 2017-03-31 2023-05-23 学校法人庆应义塾 并用抗癌剂的感受性判定标记
CN107589196B (zh) * 2017-11-02 2019-09-20 浙江高美生物科技有限公司 一种预示肺癌脑转移的小分子标志物及在诊断方面的应用
CN108362804B (zh) * 2018-02-27 2019-01-29 山东英盛生物技术有限公司 一种检测血液样品中dha含量的方法及试剂盒
EP4045905A4 (en) * 2019-10-17 2023-10-11 Biomark Cancer Systems Inc. METHOD OF DIAGNOSING EARLY STAGE NON-SMALL CELL LUNG CANCER
CN110749732B (zh) * 2019-11-27 2021-10-15 中南大学 诊断多发性骨髓瘤的血液代谢物标志物及应用
WO2021213494A1 (en) * 2020-04-23 2021-10-28 YatHing Biotechnology Company Limited Methods related to the diagnosis of prostate cancer
CN111721751A (zh) * 2020-06-30 2020-09-29 四川大学华西医院 一种检测结直肠恶性肿瘤的装置
JP2023533959A (ja) * 2020-07-08 2023-08-07 ボード オブ レジェンツ，ザ ユニバーシティ オブ テキサス システム 前立腺がんの検出及び治療方法
CN111999404A (zh) * 2020-08-14 2020-11-27 中元伯瑞生物科技(珠海横琴)有限公司 神经酸在制备甲状腺恶性肿瘤的检测试剂中的应用
CN112748195A (zh) * 2020-12-23 2021-05-04 沈阳农业大学 一种利用gc-nci-ms对脂肪酸、氨基酸和多官能团有机酸同时检测的方法
CN112630363A (zh) * 2020-12-31 2021-04-09 四川大学华西医院 一种MXene生物响应特性代谢组学分析方法
CN114527222B (zh) * 2022-02-22 2024-08-06 广州市番禺区中心医院 前列腺癌相关标志物及其应用
US20250369973A1 (en) * 2022-09-02 2025-12-04 Baker Heart and Diabetes Institute Prognostic markers
US20250076301A1 (en) * 2023-09-05 2025-03-06 National Taiwan University Biomarker for prostate cancer
CN118091155B (zh) * 2024-02-29 2025-02-18 汕头大学医学院第二附属医院 大肠癌代谢标志物及其在诊断大肠癌中的应用
CN118604356A (zh) * 2024-06-06 2024-09-06 温州医科大学 用于前列腺癌风险分层的无创诊断生物标志物组合及其应用
CN119269471B (zh) * 2024-09-19 2026-03-20 青岛大学 基于拉曼光谱的肿瘤细胞转移能力检测方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540884A (en) 1982-12-29 1985-09-10 Finnigan Corporation Method of mass analyzing a sample by use of a quadrupole ion trap
US5397894A (en) 1993-05-28 1995-03-14 Varian Associates, Inc. Method of high mass resolution scanning of an ion trap mass spectrometer
JP2005526962A (ja) 2002-02-28 2005-09-08 メタノミクス ゲーエムベーハー ウント ツェーオー．カーゲーアーアー 物質の混合物を分析する質量分析方法
EP1862797A4 (en) * 2005-03-16 2009-09-16 Ajinomoto Kk DEVICE, METHOD, SYSTEM AND PROGRAM FOR EVALUATING BIOLOGICAL STATES, DEVICE, METHOD AND PROGRAM FOR GENERATING AN EVALUATION FUNCTION AND RECORDING MEDIUM
US20070231822A1 (en) * 2006-02-28 2007-10-04 Michael Mitas Methods for the detection and treatment of cancer
EP2339346B1 (en) * 2006-03-24 2014-09-03 Metanomics GmbH Methods for predicting diabetes type II
CN101454331A (zh) * 2006-03-24 2009-06-10 菲诺梅诺米发现公司 有效用于诊断前列腺癌的生物标记，及其方法
US20090075284A1 (en) * 2006-09-19 2009-03-19 The Regents Of The University Of Michigan Metabolomic profiling of prostate cancer
EP2657705A3 (en) * 2006-09-19 2013-12-25 Metabolon Inc. Biomarkers for prostate cancer and methods using the same
EP2597464B1 (en) * 2007-08-16 2015-02-25 The Regents of the University of Michigan Metabolomic profiling of prostate cancer
US7989630B2 (en) * 2008-04-30 2011-08-02 National Institutes Of Health Represented By The Secretary Of The Department Of Health And Human Services, National Institutes Of Health Radiotracers for imaging P-glycoprotein function
US20120004854A1 (en) * 2008-05-28 2012-01-05 Georgia Tech Research Corporation Metabolic biomarkers for ovarian cancer and methods of use thereof

Also Published As

Publication number Publication date
JP2012529021A (ja) 2012-11-15
EP2804001A3 (en) 2015-01-14
EP2438445B1 (en) 2014-07-16
EP2804001B1 (en) 2017-08-09
JP2016153808A (ja) 2016-08-25
EP2438445A1 (en) 2012-04-11
PL2438445T3 (pl) 2014-12-31
US20120122243A1 (en) 2012-05-17
JP5933432B2 (ja) 2016-06-08
WO2010139711A1 (en) 2010-12-09
CN102483416A (zh) 2012-05-30
DE112010002253T5 (de) 2013-01-03
CA2764049A1 (en) 2010-12-09
JP6427137B2 (ja) 2018-11-21
EP3296743A1 (en) 2018-03-21
EP2804001A2 (en) 2014-11-19

Similar Documents

Publication Publication Date Title
ES2516866T3 (es) Medios y métodos para el diagnóstico de carcinomas de próstata
ES2522818T3 (es) Procedimientos de predicción de diabetes Tipo II
EP2863227B1 (en) Means and methods for metabolic differentiation of non-alcoholic steatohepatitis from liver disease
AU2016266098B2 (en) Means and methods for diagnosing heart failure in a subject
ES2358846T3 (es) Medios y método para predecir diabetes tipo ii.
Chen et al. Metabolomics: a promising diagnostic and therapeutic implement for breast cancer
EP2577314A2 (en) Means and methods for diagnosing pancreatic cancer in a subject
US20140323352A1 (en) Means and Methods for Diagnosing Pancreatic Cancer in a Subject
Kałużna-Czaplińska et al. Current applications of chromatographic methods for diagnosis and identification of potential biomarkers in cancer
Kozar et al. Identification of novel diagnostic biomarkers in endometrial cancer using targeted metabolomic profiling
ES2686542T3 (es) Medios y procedimientos para determinar una cantidad normalizada de aclaramiento de un biomarcador de enfermedad metabólica en una muestra
ES2688121T3 (es) Medios y procedimientos de diagnóstico de la reaparición de cáncer de próstata después de prostatectomía
ES2734810T3 (es) Uso de SM_Esfingomielina (D18:1, C16:0) como un marcador para insuficiencia cardiaca
ES2717458T3 (es) Dispositivo y procedimientos para diagnosticar cáncer de páncreas